Search
Drug Programs
You may be eligible for coverage or cost assistance of approved medications and supplies if you meet the financial criteria, or if you have a medical condition identified in one of the following Drug Programs: Catastrophic Drug Program The Catastrophic Drug Program caps the...
Poverty Elimination Strategy Act Annual Report 2024-25
The Poverty Elimination Strategy Act became law in May 2021.
PEI Biosimilar Initiative
Some drugs are made using living organisms or their cells. These drugs are called biologics. The first version of a biologic drug to be produced is called the originator or reference biologic. Biosimilars are highly similar versions of originator biologic drugs. They are produced when the patent expires on the originator biologic drug. Biosimilars are less expensive drugs that are reviewed by Health Canada to ensure they work in the same way as the originator biologic drugs and are equally effective. Through the PEI Biosimilar Initiative, coverage under PEI Pharmacare for certain biologic...
Department of Health and Wellness Business Plan 2025-2026
The Department of Health and Wellness Business Plan 2025-2026 reflects planned initiatives in the Department of Health and Wellness over the 2025-2026 fiscal year, related to the Provincial Health Plan 2023-2028.
Loving Care: Parents and Families
This book contains information for parents and families. It includes information about parent care and family care, including topics such as postpartum care, mental health, family safety, eating for wellness, siblings, and childcare.
Department of Finance Annual Report 2024-2025
This publication is the Annual Report for the Department of Finance for the fiscal year ending March 31, 2025.
A Guide to Applying Gender and Diversity Analysis in Health
Women and Gender-Diverse People’s Health Section created A Guide to Applying Gender and Diversity Analysis (GDA) in Health for staff in the health sector.